Protagonist Therapeutics (NASDAQ:PTGX – Free Report) had its target price upped by Citizens Jmp from $69.00 to $102.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have a market outperform rating on the stock. A number of other analysts have also recently commented on the company. BMO Capital Markets restated [...]
Protagonist Therapeutics (NASDAQ:PTGX) Price Target Raised to $102.00
